TransCode Therapeutics
(NASDAQ:RNAZ)
$0.5047
-0.0421[-7.70%]
At close: Apr 16
$0.5047
0[0.00%]
After Hours: 6:41PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

TransCode Therapeutics Stock (NASDAQ:RNAZ), Quotes and News Summary

TransCode Therapeutics Stock (NASDAQ: RNAZ) stock price, news, charts, stock research, profile.

Open$0.530
Close$0.505
Volume / Avg.424.250K / 699.300K
Day Range0.470 - 0.530
52 Wk Range0.500 - 356.000
Market Cap$2.931M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
25
Short Interest
0.69%
Days to Cover1

Recent News

Why Nextracker Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of Nextracker Inc. (NASDAQ: NXT) rose sharply during today’s pre-market trading after the company reported better-than-expected thi
Avi Kapoor
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.
Avi Kapoor
Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partnership with GCT Semiconductor to develop an RF module. Airspan Networks Holdings shares surged 381% to $0.3699 on Wednesday.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Oct 23
2
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About TransCode Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disea...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RNAZ
DRMA

FAQ

Q

How do I buy TransCode Therapeutics (RNAZ) stock?

A

You can purchase shares of TransCode Therapeutics (NASDAQ: RNAZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are TransCode Therapeutics's (RNAZ) competitors?

A

Other companies in TransCode Therapeutics’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Tharimmune (NASDAQ:THAR), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).

Q

What is the target price for TransCode Therapeutics (RNAZ) stock?

A

The latest price target for TransCode Therapeutics (NASDAQ: RNAZ) was reported by HC Wainwright & Co. on Tuesday, April 16, 2024. The analyst firm set a price target for 3.00 expecting RNAZ to rise to within 12 months (a possible 494.41% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for TransCode Therapeutics (RNAZ)?

A

The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $0.5047 last updated Today at April 16, 2024 at 6:41 PM EDT.

Q

Does TransCode Therapeutics (RNAZ) pay a dividend?

A

There are no upcoming dividends for TransCode Therapeutics.

Q

When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?

A

TransCode Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is TransCode Therapeutics (RNAZ) going to split?

A

There is no upcoming split for TransCode Therapeutics.

Q

What sector and industry does TransCode Therapeutics (RNAZ) operate in?

A

TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch